ライフサイエンスコーパス: tissue valve

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 r TAVR with a balloon expandable pericardial tissue valve.

2 atrix biology of degeneration in replacement tissue valves.

3 .4%) underwent valvular replacement surgery (tissue valve, 44.3%; nontissue valve, 55.7%).

4 Of 369 patients (28%) who received tissue valves, 75% had aortic valve replacement, 20% had

5 Mechanical valves and stented tissue valves allow "off the shelf" easy availability as

6 Stent mounted tissue valves also continue to exhibit limited durabilit

7 Two-year survival estimates were 61.5% for tissue-valve and 59.5% for nontissue-valve patients (P=0

8 Bioprosthetic tissue valves are the valves of choice in all the above

9 with a balloon-expandable bovine pericardial tissue valve by either a transfemoral or transapical app

10 ovide a better estimate of the durability of tissue valves for these patients.

11 a transcatheter heart valve within a failed tissue valve has been established.

12 In patients > or =70 years, tissue valves in both positions have the best in-hospita

13 The indications for tissue valves in the aortic and mitral positions are bec

14 disease proscribe the use of bioprosthetic (tissue) valves in hemodialysis patients.

15 Use of tissue valves increased from 13% in 1991 to 1995 to 38%

16 pital mortality was 14.0% overall, 11.4% for tissue-valve patients, and 15.0% for nontissue-valve pat

17 ients with mitral valve disease, options for tissue valve replacement are a stented porcine or perica

18 ement and repair (eg, cell/matrix biology of tissue valve substitutes and their degeneration and dura

19 t of diseased heart valves by mechanical and tissue valve substitutes is now commonplace and generall

20 unstented autograft, allograft, or xenograft tissue valves that best preserve this normal pattern of

21 he 2-year survival rate was 39.7+/-3.5% with tissue valves versus 39.7+/-1.4% for nontissue valves.

22 with nontissue prosthetic valves, the use of tissue valves was not predictive of death (RR 0.98; 95%

23 Tissue valves were used in 881 patients.

24 Despite the known finite durability of tissue valves, which is the main limitation in their use

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。